-dronic acid
A bisphosphonate: slows bone breakdown; used in osteoporosis.
- Drugs ending in -dronic acid: 11
- Approved somewhere: 7
- With a US drug page: 0
- Stem
- -dronic acid
- Class
- Bisphosphonates, which slow bone loss
Approved and clinical-stage drugs in ChEMBL whose names ending in -dronic acid, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Alendronic acid | Approved | FDPS | Farnesyl diphosphate synthase inhibitor |
| Etidronic acid | Approved | ATP | ATP inhibitor |
| Ibandronic acid | Approved | FDPS | Farnesyl diphosphate synthase inhibitor |
| Pamidronic acid | Approved | FDPS | Farnesyl diphosphate synthase inhibitor |
| Risedronic acid | Approved | FDPS | Farnesyl diphosphate synthase inhibitor |
| Tiludronic acid | Approved | ATP | ATP inhibitor |
| Zoledronic acid anhydrous | Approved | FDPS | Farnesyl diphosphate synthase inhibitor |
| Clodronic acid | Phase 3 | — | — |
| Medronic acid | Phase 3 | — | — |
| Minodronic acid | Phase 3 | FDPS | Farnesyl diphosphate synthase inhibitor |
| Neridronic acid | Phase 3 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO